ABMD - Replacement Heart System Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ABMD - Replacement Heart System

ABMD 381.02

0.0%

Jan 3 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: High-Tech East who wrote (39)	1/30/2001 4:50:58 PM
From: Lynn	of 147

ABMD rated a 'BUY' by Banc of America Securities 1/30/01 11:40 AM Source: News.com Mid-Day Viewpoints: ABIOMED, INC.* (ABMD) BUY Price: $25.19 Target Price: $45 AbioMed gets FDA Green Light to Start Human Implants. AbioMed received an FDA approval of its clinical trial plan (an IDE -- investigational device exemption) to test its total replacement heart in humans. The replacement heart, called the AbioCor, has been in countless calves and has undergone rigorous bench testing and will soon be “road tested”. investor.cnet.com Lynn

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next